Journal of Virus Eradication (Dec 2017)
HIV-specific T cells expressing an X5-GPI artificial receptor can suppress hiv replication in vitro: implications for a cure strategy for HIV-positive individuals with hematologic malignancies
- S. Patel,
- R.B. Jones,
- J. Kimata,
- C.M. Bollard,
- C.R. Cruz,
- S.-H. Huang,
- K. Wright,
- S. Albihani,
- A. Misra,
- P. Zhou,
- C. Russell Cruz
Affiliations
- S. Patel
- Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA; Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington DC, USA
- R.B. Jones
- Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington DC, USA
- J. Kimata
- Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA
- C.M. Bollard
- Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA; Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington DC, USA
- C.R. Cruz
- Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA
- S.-H. Huang
- Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington DC, USA
- K. Wright
- Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA
- S. Albihani
- Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA
- A. Misra
- Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA
- P. Zhou
- Unit of Anti-Viral Immunity and Genetic Therapy, Institut Pasteur of Shanghai-Chinese Academy of Sciences, Shanghai, China
- C. Russell Cruz
- Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA; Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington DC, USA
- Journal volume & issue
-
Vol. 3
p. 53